The North America and Europe pet birds health market size is anticipated to reach USD 849.8 million by 2030 and is projected to grow at a CAGR of 7.80% from 2024 to 2030. The growing prevalence of bacterial infections in pet birds, rising adoption of pet insurance, and increasing birds ownership are key factors driving the market growth. Moreover, the increasing availability and development of specialized pharmaceuticals and supplements for pet birds are vital. These products address common health issues, such as nutritional deficiencies, respiratory conditions, and organ function, contributing to market growth.
The increasing adoption of pet bird health insurance is contributing significantly to the market growth. As bird ownership rises, more pet owners seek to provide comprehensive care for their birds, driving demand for specialized health insurance plans. With insurance covering a range of veterinary services, owners are more inclined to seek timely and proper medical care for their birds, boosting demand for veterinary services, pharmaceuticals, and diagnostic tools. This, in turn, stimulates growth in the broader pet bird health market as more advanced and specialized care becomes accessible through insurance coverage. For instance, Nationwide offers pet insurance plans for birds. The insurance plans cover conditions that specifically affect birds, from internal parasites to liver disease. Moreover, according to Nationwide, a bird insurance plan's monthly premium typically starts at less than USD 21 per month and varies depending on the type of coverage chosen.
The rising prevalence of diseases in birds significantly drives the market by increasing the demand for specialized healthcare services and products. According to an article published by the World Organization for Animal Health, avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Common avian diseases like psittacosis, avian influenza, and various parasitic and bacterial infections create a growing need for advanced diagnostic tools, vaccines, and treatments. Bird owners are becoming more aware of the importance of preventive healthcare, leading to increased veterinary visits, the adoption of health supplements, and demand for pharmaceuticals designed specifically for birds. Technological advancements in diagnostics, along with the development of more effective vaccines and treatments, are further accelerating this market. In addition, the growing focus on avian wellness by breeders and pet owners, in response to disease risks, boosts sales in both diagnostic and pharmaceutical segments. E-commerce platforms also make it easier to access a wider range of bird-specific health products, increasing their availability and driving market growth.
This product will be delivered within 1-3 business days.
The increasing adoption of pet bird health insurance is contributing significantly to the market growth. As bird ownership rises, more pet owners seek to provide comprehensive care for their birds, driving demand for specialized health insurance plans. With insurance covering a range of veterinary services, owners are more inclined to seek timely and proper medical care for their birds, boosting demand for veterinary services, pharmaceuticals, and diagnostic tools. This, in turn, stimulates growth in the broader pet bird health market as more advanced and specialized care becomes accessible through insurance coverage. For instance, Nationwide offers pet insurance plans for birds. The insurance plans cover conditions that specifically affect birds, from internal parasites to liver disease. Moreover, according to Nationwide, a bird insurance plan's monthly premium typically starts at less than USD 21 per month and varies depending on the type of coverage chosen.
The rising prevalence of diseases in birds significantly drives the market by increasing the demand for specialized healthcare services and products. According to an article published by the World Organization for Animal Health, avian influenza is a highly contagious viral disease that affects both domestic and wild birds. Common avian diseases like psittacosis, avian influenza, and various parasitic and bacterial infections create a growing need for advanced diagnostic tools, vaccines, and treatments. Bird owners are becoming more aware of the importance of preventive healthcare, leading to increased veterinary visits, the adoption of health supplements, and demand for pharmaceuticals designed specifically for birds. Technological advancements in diagnostics, along with the development of more effective vaccines and treatments, are further accelerating this market. In addition, the growing focus on avian wellness by breeders and pet owners, in response to disease risks, boosts sales in both diagnostic and pharmaceutical segments. E-commerce platforms also make it easier to access a wider range of bird-specific health products, increasing their availability and driving market growth.
North America And Europe Pet Birds Health Market Report Highlights
- The pharmaceuticals segment led the market with the largest revenue share of 58.33% in 2023. Bacterial and fungal infections are common among pet birds, necessitating the use of targeted pharmaceuticals. The availability of advanced antibiotics and antifungals tailored for birds has supported market growth
- Based on application, the bacterial infections segment led the market with the largest revenue share of 48.57% in 2023
- Based on distribution channel, the veterinary hospitals/clinics segment led the market with the largest revenue share of 49.48% in 2023
- Europe dominated the market with the largest revenue share of 54% in 2023 and is anticipated to grow at the fastest CAGR of 7% during the forecast period
The leading players in the North America and Europe Pet Birds Health market include:
- Vetafarm
- Vetnil
- AdvaCare Pharma
- Thermo Fisher Scientific Inc.
- INDICAL BIOSCIENCE GmbH
- VioVet Ltd
- Zoetis
- HomeoPet LLC.
- Merck & Co., Inc
- Johnsons
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. North America Pet Birds Health Market Variables, Trends, & Scope
Chapter 4. North America Pet Birds Health Market: By Product Estimates & Trend Analysis
Chapter 5. North America Pet Birds Health Market: By Application Estimates & Trend Analysis
Chapter 6. North America Pet Birds Health Market: By Distribution Channel Estimates & Trend Analysis
Chapter 7. North America Pet Birds Health Market: Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players in the North America and Europe Pet Birds Health market include:- Vetafarm
- Vetnil
- AdvaCare Pharma
- Thermo Fisher Scientific Inc.
- INDICAL BIOSCIENCE GmbH
- VioVet Ltd
- Zoetis
- HomeoPet LLC.
- Merck & Co., Inc
- Johnsons
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | September 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 509 Million |
| Forecasted Market Value ( USD | $ 849.8 Million |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Europe, North America |
| No. of Companies Mentioned | 11 |
